Amfora is a biotech start-up with a focus on developing crops with enhanced nutritional content.
Amfora has raised $1.0M in total funding. The most recent round was Series B. The last funding was announced in July 2021.
Amfora's investors include CSIRO, Leaps by Bayer, BayWa Venture, Spruce Capital Partners.
Amfora is headquartered in San Francisco, United States.
Amfora is a biotech start-up with a focus on developing crops with enhanced nutritional content.
Amfora is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amfora — Funding & Investors." VCBacked, July 21, 2021, https://www.vcbacked.co/company/amfora. Accessed August 23, 2026.
VCBacked. (2021). Amfora — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/amfora
{{cite web |title=Amfora — Funding & Investors |url=https://www.vcbacked.co/company/amfora |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated